Increasingly complex biological problems and extremely large biological data sets have necessitated new approaches to answer many of today’s current research challenges and tackle emerging questions in biology not amenable to traditional approaches.  As one of the fields in the “New Biologies”, Computational and Systems Biology (CSB) encompasses an interdisciplinary approach that harnesses the power of computation and systems-level analyses to formulate and solve critical biological problems.  These research programs within CSB also synergize and collaborate with the extensive basic and clinical research programs at the University of Pittsburgh and across the globe.  Concomitant with our research foci, CSB is also a leader in educating and training all levels of emerging and nascent scientists, who will continue this work and identify and tackle new biological problems of the next generation.

NSF Graduate Research Fellowship Program offers awards to Caroline Larkin, April Rich and Gaby Gerlach
The 2021 NSF Graduate Research Fellowship Program (GRFP) has offered awards to Caroline Larkin (Faeder/Shoemaker Labs) and April Rich (Carvunis Lab), while Gaby Gerlach (Camacho Lab) has received an honorable mention. Congratulations! (read more)

Samantha Furman awarded NIH NCI fellowship
Samantha Furman awarded NIH NCI F31 Ruth L. Kirschstein Predoctoral National Research Service Award to support her PhD work titled “Quantifying heterocellular communication and.... (read more)

Anne-Ruxandra Carvunis selected as a 2021 Alfred P. Sloan Research Fellow
Congratulations to Anne-Ruxandra Carvunis on being selected as a 2021 Alfred P. Sloan Research Fellow for her work in Computational & Evolutionary Molecular Biology.... (read more)

DCSB Welcomes Yu-Chih Chen to the faculty
It is with great pleasure that we welcome Dr. Yu-Chih Chen to our Department as an Assistant Professor in the tenure stream effective November 2020.... (read more)

DCSB Welcomes Dr. Nathan Lord to our academic family!
It is with great pleasure that we welcome Dr. Nathan Lord to our Department as an Assistant Professor in the tenure stream effective September 2020... (read more)

Bahar Lab and Cedars-Sinai Study Shows How COVID-19 Could Lead to Runaway Inflammation

A study from the University of Pittsburgh School of Medicine and Cedars-Sinai addresses a mystery first raised in March: Why do some people with COVID-19 develop severe inflammation? The research shows how the molecular structure and sequence of the SARS-CoV-2 spike protein—part of the virus that causes COVID-19—could be behind the inflammatory syndrome cropping up in infected patients...
(Read More: PittWire, UPMC, TribLive, Cedars-Sinai)

TECBio REU Pioneers Successful Virtual Program

Amidst the uncertainty and turmoil that beleaguered the early months of 2020, the TECBio Research Experience for Undergraduates (REU) program at the University of Pittsburgh had to make the difficult decision of whether or not to proceed with their annual summer research program. Preparations had to be made and longstanding playbooks had to be completely re-written, but it was decided that the program would continue... (read more)

Robin Lee Promoted to Associate Professor
Congratulations to Dr. Robin Lee on his promotion to Associate Professsor! (read more)

Pitt prepares to resume research The University of Pittsburgh is making preparations to resume research activities on campus amidst the COVID-19 pandemic. On Friday, Chancellor Patrick Gallagher issued a statement outlining the goals of re-opening the university by saying, "we are seeking to adapt to a new reality: performing our vital mission and protecting our community in the midst of a pandemic." In his message... (read more)

Dr. Ivet Bahar has been elected a member of The National Academy of Sciences
Dr. Ivet Bahar is among the exceptional scientists elected this year to the The National Academy of Sciences (NAS). NAS membership is a widely accepted mark of excellence in science and is considered one of the highest honors that a scientist can receive... (read more)